Abramson Cancer Center at Penn Medicine: Leukemia trials
The registry lists 12 Leukemia studies with Abramson Cancer Center at Penn Medicine as lead sponsor. 1 are open to participants now and 3 have results posted.
Early Phase 1 1Phase 1 4Phase 2 5No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic MalignanciesRecruitingNCT03680677
- A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic LeukemiaTerminatedNCT01486784Phase 1/2Results posted
- Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)TerminatedNCT01113502Phase 1/2Results posted
- Phase II Study of Bexarotene in Patients With Acute Myeloid LeukemiaTerminatedNCT00615784Phase 2Results posted
- Cardiovascular Effects of CART Cell TherapyCompletedNCT04026737
- Cardiovascular Function in Acute LeukemiaCompletedNCT03760237
- Clonal Evolution of B Cells in High-risk CLL After Idelalisib-rituximabWithdrawnNCT02993536
- IFN-DLI for Relapsed Acute Leukemia After Allo-SCTCompletedNCT02331706Early Phase 1
- Study of Efficacy and Safety of CTL019 in Adult ALL PatientsWithdrawnNCT02167360Phase 2
- Sirolimus in Combination With MEC in High Risk Myeloid LeukemiasCompletedNCT00780104Phase 1
- Study of Bexarotene in Patients With Acute Myeloid LeukemiaCompletedNCT00316030Phase 1
- Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002592Phase 2